3.0
Feb 27, 2026
Former employee, more than 3 years
Atenas, , Ática
Recommend
CEO approval
Business Outlook
Pros
Structure, stability, size, aknowledged, highly pespected in oncology
Cons
Limited carreer growth, lean pipeline, loe of blockbuster without stong successor